DEERFIELD MANAGEMENT COMPANY, L.P. Q2 2018 Filing
Filed August 14, 2018
Portfolio Value
$2.8T
Holdings
113
Report Date
Q2 2018
Filing Type
13F-HR
All Holdings (113 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | —IGI LABORATORIES INC | 3,733,000 | $3.5B | 0.12% | |
| 102 | —FOAMIX PHARMACEUTICALS LTD | 674,002 | $3.4B | 0.12% | |
| 103 | STIMNEURONETICS INC | 125,000 | $3.3B | 0.12% | |
| 104 | —PROTEON THERAPEUTICS INC | 1,224,899 | $3.0B | 0.11% | |
| 105 | MNKDMANNKIND CORP | 1,458,537 | $2.8B | 0.10% | |
| 106 | —NUVECTRA CORP | 131,000 | $2.7B | 0.09% | |
| 107 | —TELIGENT INC NEW | 708,873 | $2.5B | 0.09% | |
| 108 | VYGRVOYAGER THERAPEUTICS INC | 117,647 | $2.3B | 0.08% | |
| 109 | KIDSORTHOPEDIATRICS CORP | 80,783 | $2.2B | 0.08% | |
| 110 | —EYENOVIA INC | 300,000 | $1.9B | 0.07% | |
| 111 | XNCRXENCOR INC | 48,366 | $1.8B | 0.06% | |
| 112 | —NEOS THERAPEUTICS INC | 233,332 | $1.5B | 0.05% | |
| 113 | —ARALEZ PHARMACEUTICALS INC | 1,644,583 | $576.0M | 0.02% |
PreviousPage 2 of 2